Furthermore, it is likely that TRPA1 phosphorylation contributes to other painful pathologies associated with the ligand-gated ion channel, including chemotherapy-induced peripheral neuropathy (CIPN50, 78) and/or nerve crush/ligation79). The gene discussed is GLRA3; the disease is peripheral neuropathy.